Loading company…
RISORIUS develops AI tools that analyze brainwave data to support medical decisions.
Its platform helps doctors assess neurological disorders and select medications. Its DRNET product predicts central nervous system drug response using electroencephalogram data. Founded in 2023, RISORIUS is based in Seoul, South Korea, and is led by CEO Bae Sang Yoon as of 2026. In March 2026, it raised venture funding from Seoul Technology Holdings.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in